APRINOIA Therapeutics Inc. (APRI)

APRINOIA Therapeutics was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$10.00 - $12.00

Shares Offered

500,000

Deal Size

$5.50M

APRINOIA Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-21.74	-28.23	-23.26
Depreciation & Amortization	0.54	0.44	0.32
Share-Based Compensation	-	1.91	0.91
Other Operating Activities	8.32	8.64	-2.27
Operating Cash Flow	-12.88	-17.24	-24.3
Capital Expenditures	-1.26	-2.02	-0.5
Other Investing Activities	-0.66	-	0.18
Investing Cash Flow	-1.92	-2.02	-0.32
Share Issuance / Repurchase	-	9	31.67
Debt Issued / Paid	-	3.09	-0.18
Other Financing Activities	15.64	-0.74	-
Financing Cash Flow	15.64	11.35	31.49
Net Cash Flow	0.04	-8.45	6.81
Free Cash Flow	-14.14	-19.25	-24.8
Free Cash Flow Margin	-154.81%	-4886.55%	-4509.09%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).